Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-18

Clinical Trial Update: Is Protein S100B a Predictor of First-to-chronic Seizure Conversion in Adults?

View source ↗

Summary

A terminated clinical trial examined whether S100B protein levels can predict progression from a first seizure to chronic epilepsy in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Epilepsy, Seizures, Epileptic | Status: TERMINATED